HC

Hastimal Chordia

Active Director Director DIN 07830974
DIN 07830974 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Total affiliations 8 Since May 2018
Shareholding value •••• Premium profile

About Hastimal Chordia

Data last updated:

Hastimal Chordia is a Director at Tablets Medopharm Private Limited (since 2024), Director at Medopharm Life Foundation (since 2021) and Director at Achord Aggro Private Limited (since 2018), and holds 5 more current directorships. The companies operate in Pharma, Non-Profit Organizations and Agriculture. The 3 current companies with reported revenue have a combined latest revenue of ₹19.05 Cr; the largest is Tablets Medopharm Private Limited at ₹18.97 Cr (FY 2025).

DIN 07830974
Primary Designation Director
Industry Pharma
First Appointment 31 May 2018
Oldest Company Age 8 yrs
Largest company Tablets Medopharm Private Limited · ₹18.97 Cr (FY 2025)
Combined revenue ₹19.05 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tablets Medopharm Private Limited U51909TN2019PTC130558
Director20 Mar 20242019₹18.97 Cr (FY 2025)Active
Medopharm Life Foundation U85300TN2021NPL141625
Director25 Feb 20212021₹6.5 Lakh (FY 2025)Active
Achord Aggro Private Limited U01110TN2018PTC123084
Director06 Jun 20182018₹2 Lakh (FY 2022)Active
Designated Partner26 Dec 20252025Active
Director01 May 20252025Active
Director01 Oct 20242024Active
Glo Q Innovations Private Limited U20237TN2024PTC169485
Director16 Apr 20242024Active
Designated Partner31 May 20182018Active

Directorship timeline

Open interactive timeline →
Go Aawesome Venturz Llp
Achord Aggro Private Limited
Medopharm Life Foundation
Satranggi Swad Llp
Premium access

Shareholding and investment profile for Hastimal Chordia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hastimal Chordia

Hastimal Chordia currently holds 8 directorships: Tablets Medopharm Private Limited (Director, since 20 Mar 2024, revenue ₹18.97 Cr (FY 2025)); Medopharm Life Foundation (Director, since 25 Feb 2021, revenue ₹6.5 Lakh (FY 2025)); Achord Aggro Private Limited (Director, since 06 Jun 2018, revenue ₹2 Lakh (FY 2022)); Satranggi Swad Llp (Designated Partner, since 26 Dec 2025); Phar & Vide Life Sciences Private Limited (Director, since 01 May 2025); and 3 more.

Hastimal Chordia was first appointed on 31 May 2018 as Designated Partner at Go Aawesome Venturz Llp. The most recent appointment on record is 26 Dec 2025 at Satranggi Swad Llp.

The 3 current companies of Hastimal Chordia that report revenue have a combined latest revenue of ₹19.05 Cr: Tablets Medopharm Private Limited ₹18.97 Cr (FY 2025); Medopharm Life Foundation ₹6.5 Lakh (FY 2025); Achord Aggro Private Limited ₹2 Lakh (FY 2022).

The current boards of Hastimal Chordia's companies include Balamurugan Rengasamy (Tablets Medopharm Private Limited), Siddhartha Daga (Tablets Medopharm Private Limited), Tushar Chordia (Tablets Medopharm Private Limited), Prakash Chordia (Medopharm Life Foundation), Narrindar Chordia (Achord Aggro Private Limited), Udhan Kumar Chordia (Achord Aggro Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available